Notes And Other Explanatory Information [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accounting judgements and estimates [text block] |
Note 3A - Estimates and judgements
|
| Disclosure of allowance for credit losses [text block] |
Movement in provisions for credit losses (trade receivables)
|
| Disclosure of auditors' remuneration [text block] |
Note 32 - Auditor’s fees
|
| Disclosure of authorisation of financial statements [text block] |
The financial statements were authorised by the Board of Directors on March 25, 2025
|
| Disclosure of basis of consolidation [text block] |
Consolidation
|
| Disclosure of biological assets, agriculture produce at point of harvest and government grants related to biological assets [text block] |
Note 6 - Biological assets
|
| Disclosure of borrowing costs [text block] |
The following programmes are the main sources of financing for the Mowi Group as of
|
| Disclosure of borrowings [text block] |
Note 11 - Interest-bearing debt
|
| Disclosure of cash flow statement [text block] |
Cash movements financing activities
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
Note 33 - New IFRS standards
|
| Disclosure of collateral [text block] |
Note 19 - Secured liabilities and guarantees
|
| Disclosure of commitments [text block] |
Contractual commitments
|
| Disclosure of contingent liabilities [text block] |
Note 27 - Contingent liabilities and provisions
|
| Disclosure of credit risk [text block] |
Credit risk
|
| Disclosure of deferred taxes [text block] |
Note 15 - Taxes
|
| Disclosure of derivative financial instruments [text block] |
|
| Disclosure of dividends [text block] |
Leverage and capital access
|
| Disclosure of earnings per share [text block] |
Note 25 - Earnings per share
|
| Disclosure of employee benefits [text block] |
Note 14 - Remuneration
|
| Disclosure of entity's operating segments [text block] |
Note 4 - Business segments
|
| Disclosure of events after reporting period [text block] |
Note 34 - Subsequent events
|
| Disclosure of fair value of financial instruments [text block] |
Fair value of financial instruments
|
| Disclosure of financial instruments [text block] |
Note 12 - Financial instruments
|
| Disclosure of financial instruments at fair value through profit or loss [text block] |
|
| Disclosure of goodwill [text block] |
Note 9 - Intangible assets
|
| Disclosure of impairment of assets [text block] |
Note 8 - Impairment testing of intangible assets
|
| Disclosure of information about key management personnel [text block] |
|
| Disclosure of interest expense [text block] |
|
| Disclosure of inventories [text block] |
Note 7 - Inventory
|
| Disclosure of issued capital [text block] |
Note 24 - Share capital
|
| Disclosure of joint ventures [text block] |
Note 21 - Investments in associated companies and interest in joint ventures
|
| Disclosure of leases [text block] |
Note 29 - Leases
|
| Disclosure of liquidity risk [text block] |
Price/liquidity risk
|
| Disclosure of market risk [text block] |
Currency risk
|
| Disclosure of material accounting policy information [text block] |
Note 2 - Accounting policies
|
| Disclosure of non-current assets or disposal groups classified as held for sale [text block] |
Note 22 - Business combinations, assets held for sale and discontinued operations
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
Note 13 - Capital management and risk management
|
| Disclosure of other liabilities [text block] |
Note 18 - Trade payables and other current liabilities
|
| Disclosure of other non-current liabilities [text block] |
Note 20 - Other non-current liabilities
|
| Disclosure of other operating expense [text block] |
Note 28 - Other operating expenses
|
| Disclosure of prepayments and other assets [text block] |
Note 17 - Trade receivables, other receivables and prepayments
|
| Disclosure of property, plant and equipment [text block] |
Note 10 - Property, plant and equipment
|
| Disclosure of related party [text block] |
Note 26 - Related party transactions
|
| Disclosure of research and development expense [text block] |
Note 31 - Research and development
|
| Disclosure of restricted cash and cash equivalents [text block] |
Note 16 - Cash
|
| Disclosure of revenue [text block] |
Note 5 - Disaggregation of revenue
|
| Disclosure of share-based payment arrangements [text block] |
Share option scheme
|
| Disclosure of subsidiaries [text block] |
Note 23 - Consolidated entities
|
| Disclosure of tax receivables and payables [text block] |
|
| Disclosure of treasury shares [text block] |
|